L'Oreal acquires an entire Indian D2C alliance - the lesson for Japanese companies

French cosmetics giant L'Oreal announced on June 18, 2026 that it had agreed to acquire a majority stake in Innovist, an Indian science-led D2C group. Innovist is a "house of brands" bundling together Bare Anatomy in hair care, Chemist at Play in skincare, and SunScoop in sunscreen. Its three founders will remain as minority shareholders, continuing the business in partnership with L'Oreal India. For Japanese consumer goods and cosmetics makers considering entry into India, this is more than just overseas news - it is an example of the latest model for entering India, in which a global giant acquires an entire local D2C group, brand by brand.

The triggering news: majority stake acquired, the three founders stay on

According to L'Oreal's announcement, the acquisition covers a majority stake in Innovist as a whole. The three founders - Rohit Chawla (CEO), Sifat Khurana (CMO), and Vimal Bhola (head of R&D) - will remain as minority shareholders, continuing to lead management and brand operations. The deal is expected to close within the coming months, subject to regulatory approvals. Neither company has disclosed the acquisition price. Some reports estimate it at 350-450 million dollars, but this is a secondhand estimate, not an officially confirmed figure.

In the announcement, L'Oreal CEO Nicolas Hieronimus said that combining L'Oreal's global expertise with Innovist's science-led products and understanding of Indian consumers would "shape the future of beauty in this growth market." The founders, for their part, cited alignment in product philosophy and access to global scientific research resources as reasons for the deal.

What is Innovist: an engine for mass-producing brands through a science-led pitch

Innovist is a startup founded in 2018 that has run multiple brands in parallel, united by a common emphasis on ingredient transparency and evidence-based claims. Bare Anatomy targets hair care, Chemist at Play targets skincare and body care, SunScoop targets sunscreen, and Vinci Botanicals targets a plant-based line - each aimed at a distinct category. Rather than betting everything on a single brand, its defining feature is raising multiple flags on top of shared research, sourcing, and logistics.

On performance, the company is reported to have reached revenue of about INR 2.99 billion (₹299 crore) in the fiscal year ending March 2025 (FY25), up 2.8 times from about INR 1.058 billion the previous year, and to have turned profitable (roughly 5.4 billion yen at an exchange rate of about 1 rupee = 1.8 yen). On the funding side, it raised about INR 1.36 billion (₹136 crore) in a Series B round involving investors such as the Amazon Smbhav Venture Fund and Sauce.vc, with early investor Accel reportedly exiting in that round. This case stands as one complete example of the pattern in which VC money is used to launch multiple brands at once, and once profitability comes into view, a global giant acquires the whole group.

In numbers: what L'Oreal is paying for with Innovist

Behind L'Oreal's pursuit of Innovist are the concrete results the company built up in a short period. The acquisition price itself is undisclosed, but lining up Innovist's recent performance and funding history reveals what L'Oreal is actually buying. Estimates of the size of India's beauty and personal care market itself vary widely among research firms - reports put annual figures anywhere from 20 billion to 30 billion dollars, with equally wide-ranging growth forecasts - so this article avoids asserting a specific figure. The core of this deal is that L'Oreal has secured a rare asset - an already-profitable multi-brand group in this growth market - along with the local platform behind it.

Industry reaction: D2C exits shift from "IPO" to "sale to a major player"

Within India's startup community, some are reading this deal as showing "a visible exit path for a house of brands." One D2C industry figure points out that what stands out is not the sale of a single cosmetics brand but the acquisition of an entire group of brands together with its research function. On the investor side, the view expressed is that a D2C group that has achieved profitability becomes an immediately usable local platform for a global giant. At the same time, some see the arrangement - in which the founders remain as minority shareholders - as a compromise designed to preserve local execution capability and the brands' identity. There is also cautious commentary questioning whether the "science-led" tone of the brands might fade after the acquisition.

Implications for Japanese companies: entering by "buying or partnering" is faster than "building"

Broadly, Japanese cosmetics and consumer goods makers have three ways to enter India: building their own brand locally from scratch, investing in or partnering with a local D2C company, or, as in this case, acquiring an entire group of brands. What the Innovist case makes clear is that local consumer understanding and digital sales channels can be bought "pre-built," saving years of time. Japanese makers confident in their product strength tend to insist on building their own presence, but mastering India's channel structure and social media culture takes years.

Moves by Japanese companies are already appearing as individual data points. Wacoal has opened a flagship store in Mumbai, moving to build direct touchpoints locally (see Wacoal's Mumbai flagship store opening). In areas close to cosmetics and personal care, roll-ups by major local players are also progressing, such as Honasa (Mamaearth), a competitor to Kao, absorbing Fluence Pharma (see Honasa's acquisition of Fluence Pharma When read side by side, it becomes clear that strategy diverges depending on whether the buyer is a foreign company or a local one). Japanese companies' options are converging on either "buying a local brand" or "partnering before a local major player gets there first."

As a concrete action, there are two moves Japanese cosmetics and toiletries makers can take right now. First, build a long list of profitable, multi-brand Indian D2C companies like Innovist, and start the relationship not with a majority acquisition but with a minority investment plus OEM supply. Second, offer their own R&D and formulation strengths as contract manufacturing (OEM/ODM) behind local brands, gaining a foothold in the supply chain without waiting for an acquisition. The latter mirrors the approach proven in dried vegetables and food OEM - earning through supply without holding your own brand - and it works just as well in cosmetics.

Ripple effects on the market: foreign "acquisitions of local brand houses" become standard

If moves like L'Oreal's - where the world's largest players acquire entire brand houses rather than single brands - spread further, valuations for Indian D2C companies will rise the more they satisfy "profitability plus multiple brands." This will push local startups from the outset toward a design built on multiple brands, science-led messaging, and profitability. For Japanese makers, this means a growing risk that good acquisition and partnership targets get claimed by foreign players first. The clock has moved on from "considering entry into India someday" to "starting a stocktake of partnership candidates now." Nippon Paint's track record of absorbing a cluster of local companies in India (Nippon Paint's India strategy) is also a useful reference as the same pattern of "entering by bundling local companies together," even in a different industry.

Practical information: checkpoints for considering an Indian D2C partnership or acquisition

• Confirm, through primary sources (financial statements, corporate registration records), whether the target has been profitable in its most recent fiscal year and its year-over-year revenue growth rate
• Determine whether it is a single-brand or multi-brand company, and assess whether it has shared research and sourcing infrastructure
• Design the terms for the founding team's continued involvement (whether there is an earn-out or staged acquisition) at the contract stage
• If a majority stake is difficult to obtain, start the relationship with a minority investment plus OEM supply and secure a right of first refusal
• Work backward from regulations (FDI, cosmetics import rules, ingredient labeling rules) and the time needed to close the deal

L'Oreal's deal this time also anticipates "closing in a few months," contingent on regulatory approval. Because M&A in India takes time from agreement to closing, the earlier a company begins considering a partnership, the more options remain open.

Summary: the next move

L'Oreal's acquisition of Innovist has clarified a model in which a global major absorbs a local D2C company "brand group by brand group." The next actions Japanese cosmetics and consumer goods makers should take are threefold: (1) build a long list of profitable Indian D2C companies, (2) start the relationship through the low-risk entry point of minority investment plus OEM supply, and (3) offer their own formulation and research strength as contract manufacturing for local brands to gain a foothold in the supply network. Rather than spending years building a presence from scratch, it is worth shifting to a mindset of buying local time.

Sources

• L'Oreal - "L'Oreal to acquire a majority stake in Innovist" (official press release)
• L'Oreal Finance - Press Release (official)
• Entrackr — L’Oréal acquires majority stake in Bare Anatomy parent Innovist
• Entrackr — Innovist crosses Rs 300 Cr revenue in FY25, turns profitable
• Inc42 — Bare Anatomy Parent Innovist Bags INR 136 Cr Funding